When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Ozempic is under clinical development by Novo Nordisk and currently in Phase III for Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD).

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Ozempic has become a popular wonder drug among many Hollywood celebrities, who turned to the diabetes medication to lose ...

As weight-loss drugs have exploded in popularity this past year, part of the craze has been members of the public wondering which celebrities are on Ozempic.

Musk has been a vocal fan of weight-loss drugs. Say goodbye to cookies and candy canes. This holiday season, Elon Musk is calling himself “Ozempic Santa.” Adorned in a Santa suit in a photo ...

From weight-loss drugs to nonopioid pain killers to AI, here are some important -- and positive -- trends in health care.

Through Dec. 20, the FDA approved 50 brand new medicines, defined as proteins, small molecules, or other chemicals this year.

Novo Nordisk is planning to open an artificial intelligence (AI) research facility in London, UK, as part of a drive to place the technology at the heart of its drug discovery operations.